Gene targeting techniques for Huntington’s disease

Applying Bioinfomatics Strategies in Huntingtons Disease Research

Huntingtin and the molecular pathogenesis of Huntingtons disease

Huntington’s disease (HD) is a late-onset neurodegenerative disorder that is caused by a CAG repeat expansion in the IT15 gene, which results in a long stretch of polyglutamine close to the amino-terminus of the HD protein huntingtin (htt). The normal function of htt, and the molecular mechanisms that contribute to the disease pathogenesis, are in the process of being elucidated. In this review...

MRI Tz Hypointensities in basal ganglia of premanifest Huntingtons disease

Practice, progress and future directions for physical therapies in Huntingtons disease.

Physical therapies and exercise may have potential as a disease modifying agent in Huntington's disease (HD) and in recent years, there have been several small scale feasibility studies that have shown benefit as a result of physical interventions. When evaluating complex physical interventions, a phased approach using mixed methodology designs that report specific intervention components, adhe...

Models of human disease through gene targeting.

25 eds.), vol. 2, pp. 227-241, John Wiley & Sons, Chichester Bolger, G. ( 1 994) Cell. Signalling 6.85 1-859 Beavo, J. A., Conti, M. and Heaslip, R. J. (1994) Mol. Endocrinol. 46,399-405 Shakur, Y., Pryde, J. and Houslay, M. D. (1993) Biochem. J. 292,677-686 Lobban, M., Shakur, Y.. Beattie, J. and Houslay. M. D. (1994) Biochem. J. 304,399-406 Shakur, Y., Wilson, M., Pooley, L.. Lobban, M., Grif...